Identification of Prosthetic Joint Infection Pathogens Using a Shotgun Metagenomics Approach (original) (raw)
Journal Article
Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Search for other works by this author on:
Department of Surgery, Mayo Clinic, Rochester, Minnesota
Search for other works by this author on:
Kerryl E Greenwood-Quaintance ,
Kerryl E Greenwood-Quaintance
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
Search for other works by this author on:
Department of Surgery, Mayo Clinic, Rochester, Minnesota
Search for other works by this author on:
Department of Surgery, Mayo Clinic, Rochester, Minnesota
Search for other works by this author on:
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota
Search for other works by this author on:
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota
Search for other works by this author on:
Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
Correspondence: R. Patel, Division of Clinical Microbiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 ([email protected]).
Search for other works by this author on:
Received:
17 December 2017
Cite
Matthew J Thoendel, Patricio R Jeraldo, Kerryl E Greenwood-Quaintance, Janet Z Yao, Nicholas Chia, Arlen D Hanssen, Matthew P Abdel, Robin Patel, Identification of Prosthetic Joint Infection Pathogens Using a Shotgun Metagenomics Approach, Clinical Infectious Diseases, Volume 67, Issue 9, 1 November 2018, Pages 1333–1338, https://doi.org/10.1093/cid/ciy303
Close
Navbar Search Filter Mobile Enter search term Search
Abstract
Background
Metagenomic shotgun sequencing has the potential to change how many infections, particularly those caused by difficult-to-culture organisms, are diagnosed. Metagenomics was used to investigate prosthetic joint infections (PJIs), where pathogen detection can be challenging.
Methods
Four hundred eight sonicate fluid samples generated from resected hip and knee arthroplasties were tested, including 213 from subjects with infections and 195 from subjects without infection. Samples were enriched for microbial DNA using the MolYsis basic kit, whole-genome amplified, and sequenced using Illumina HiSeq 2500 instruments. A pipeline was designed to screen out human reads and analyze remaining sequences for microbial content using the Livermore Metagenomics Analysis Toolkit and MetaPhlAn2 tools.
Results
When compared to sonicate fluid culture, metagenomics was able to identify known pathogens in 94.8% (109/115) of culture-positive PJIs, with additional potential pathogens detected in 9.6% (11/115). New potential pathogens were detected in 43.9% (43/98) of culture-negative PJIs, 21 of which had no other positive culture sources from which these microorganisms had been detected. Detection of microorganisms in samples from uninfected aseptic failure cases was conversely rare (7/195 [3.6%] cases). The presence of human and contaminant microbial DNA from reagents was a challenge, as previously reported.
Conclusions
Metagenomic shotgun sequencing is a powerful tool to identify a wide range of PJI pathogens, including difficult-to-detect pathogens in culture-negative infections.
Prosthetic joint infections (PJIs) are devastating complications of up to 2% of total joint arthroplasties and are associated with significant morbidity and cost [1]. A wide range of pathogens can cause PJIs, including aerobic and anaerobic bacteria, and fungi [2, 3]. Polymicrobial infections are also common. Five to 20% of cases that meet clinical criteria for PJI remain culture negative, and despite advances in culture techniques and molecular biology assays, such as panel polymerase chain reaction (PCR) assays, many cases remain in which no microbiological etiology is identified [2]. In the absence of a defined pathogen, culture-negative PJIs are typically empirically treated with a broad-spectrum intravenous antimicrobial regimen to cover the many pathogens commonly associated with PJI.
Aseptic failure refers to arthroplasty failure in the absence of findings of infection. While this can encompass a wide range of etiologies, of particular interest is the phenomenon of aseptic loosening in which arthroplasty components loosen and lead to pain and mechanical failure. Microorganisms have been suspected to play a potential role in a subset of aseptic loosening cases. Previous studies using a variety of methods have demonstrated wide disparity in the frequency of organisms detected in association with aseptic loosening, leaving open the question as to whether microorganisms undetected by culture may play a role in some cases of “aseptic” failure [4, 5].
Metagenomic shotgun sequencing is a method in which all nucleic acid in a sample is extracted and sequenced using next-generation sequencing techniques, after which the resulting sequences are used to identify organisms present in the sample. This approach has been used to characterize a wide range of specimen types, including those in environmental and microbiome studies [6, 7]. Metagenomics is also gaining interest in infectious diseases diagnostics as a method to identify pathogens that are not easily detected using current techniques, such as culture or directed PCR approaches. It offers advantages over 16S ribosomal RNA (rRNA) gene “broad-range” PCR in that it is potentially able to identify any pathogen, especially when DNA- and RNA-based methods are used in combination. Further, resistance-associated genes and mutations can be identified [8]. However, metagenomic shotgun sequencing faces many challenges as well. The often overwhelming presence of human nucleic acids in samples can make detection of pathogens challenging [9]. The time and cost associated not only with sequencing but also analysis of large, complicated sets of data can also be barriers. Contaminating microbial DNA in reagents is also often encountered, making it difficult to distinguish true pathogens from background noise [10–12]. Despite these and other limitations, metagenomics research is rapidly growing and offers the potential to change how many unknown or difficult-to-detect pathogens are identified.
In prior studies involving a small number of clinical cases, we reported the use of metagenomics to identify PJI pathogens as well as the application of tools to optimize these methods [9, 13, 14]. Since then, additional studies have provided further evidence of the value of this approach for detection of PJI pathogens as well as organisms in other infection types [15–17]. Here, we report the results of shotgun metagenomic analysis of 408 sonicate fluid samples generated from resected prostheses, providing the largest cohort to date of metagenomic analysis of clinical specimens of any type. In addition, compared with recently published smaller studies, we used different sample processing methods, particularly different microbial DNA enrichment methods and sequencing techniques, which allowed for greater depth of coverage of detected organisms. With the inclusion of a large number of aseptic failure cases, we also sought to further investigate the potential role of unidentified microorganisms in the failure of these otherwise seemingly uninfected samples.
MATERIALS AND METHODS
Samples
Samples were collected under the Mayo Clinic Institutional Review Board protocol 09-00808. Sonicate fluids were prepared from resected prosthetic hip and knee components between 2011 and 2016 using previously described vortexing/sonication methods [18]. Sonicate fluids from resected antibiotic spacers and polyethylene inserts were not included. Complete clinical microbiological data were available for all samples. Pathology findings were determined by the consulting pathologist at the time of surgery. Four hundred eight samples, including culture-positive PJIs, culture-negative PJIs, and aseptic failures, were selected sequentially from a database of resected arthroplasties evaluated using sonication-based methods for culture. Use of sonication was at the operative surgeon’s discretion and therefore not performed on all resected arthroplasties at our institution during the period of sample collection. Twenty samples (from 2 preparation batches) were removed from analysis due to high levels of contaminant bacterial DNA across samples as all samples were positive for high levels of Streptococcus mitis DNA.
Sample Classification
Samples were classified as aseptic failure or PJI based on Infectious Diseases Society of America (IDSA) PJI diagnostic criteria [19]. Sonicate fluid cultures with ≥20 colony-forming units (CFU)/10 mL were considered culture positive. Two or more cultures growing the same organism were required for intraoperative tissue cultures to be considered positive.
Sample Preparation, Sequencing, and Analysis
Full details regarding sample preparation, sequencing methods, tools used for metagenomic data analysis, and interpretation of results are available in the Supplementary Methods.
Statistical Analysis
Differences in age between aseptic failure and PJI subjects were calculated using an unpaired t test. A χ2 test was used to test for differences in proportions of arthroplasty location and sex.
RESULTS
Metagenomic Shotgun Sequencing
A total of 408 sonicate fluid samples from resected hip and knee arthroplasties were analyzed using metagenomic shotgun sequencing. This included 213 samples classified by IDSA criteria as having PJI, and another 195 classified as having aseptic failure [19]. Subject demographics, classification criteria, and clinically relevant findings, including laboratory testing, are summarized in Table 1, with individual sample details available in Supplementary Table 1. An average of 28592988 paired-end reads were sequenced from each sample (range, 15133370–45274168 reads).
Table 1.
Characteristics of Subjects
| Characteristic | Aseptic Failure (n = 195) | PJI (n = 213) |
|---|---|---|
| Agea, y, mean (range) | 64.8 (18–89) | 65.8 (30–93) |
| Sexb, female, No. (%) | 106 (54) | 98 (46) |
| Site of arthroplastyc, No. (%) | ||
| Knee | 155 (79) | 126 (59) |
| Hip | 40 (21) | 87 (41) |
| IDSA PJI criteria, No. | ||
| Purulence visible intraoperatively | 0 | 130 |
| Presence of sinus tract | 0 | 52 |
| Identical organism identified with 2 separate cultures | 0 | 111 |
| Acute inflammation on histopathology | 1 of 170 | 113 of 144 |
| Antibiotics within 4 wk prior to surgery | 10 | 131 |
| Laboratory parameters, median (range) | ||
| Hemoglobin, mg/dL | 13.6 (7.2–17.7) | 11.7 (5–15.7) |
| WBC count, 103 cells/µL | 6.8 (3.0–48.6) | 7.8 (3.1–40.6) |
| ESR, mm/h (reference range, 0–22) | 9 (0–109) | 40 (1–130) |
| CRP, mg/L (reference range, 0–8.0) | 3.8 (1–245) | 31.8 (3–400) |
| Characteristic | Aseptic Failure (n = 195) | PJI (n = 213) |
|---|---|---|
| Agea, y, mean (range) | 64.8 (18–89) | 65.8 (30–93) |
| Sexb, female, No. (%) | 106 (54) | 98 (46) |
| Site of arthroplastyc, No. (%) | ||
| Knee | 155 (79) | 126 (59) |
| Hip | 40 (21) | 87 (41) |
| IDSA PJI criteria, No. | ||
| Purulence visible intraoperatively | 0 | 130 |
| Presence of sinus tract | 0 | 52 |
| Identical organism identified with 2 separate cultures | 0 | 111 |
| Acute inflammation on histopathology | 1 of 170 | 113 of 144 |
| Antibiotics within 4 wk prior to surgery | 10 | 131 |
| Laboratory parameters, median (range) | ||
| Hemoglobin, mg/dL | 13.6 (7.2–17.7) | 11.7 (5–15.7) |
| WBC count, 103 cells/µL | 6.8 (3.0–48.6) | 7.8 (3.1–40.6) |
| ESR, mm/h (reference range, 0–22) | 9 (0–109) | 40 (1–130) |
| CRP, mg/L (reference range, 0–8.0) | 3.8 (1–245) | 31.8 (3–400) |
Abbreviations: CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IDSA, Infectious Diseases Society of America; PJI, prosthetic joint infection; WBC, white blood cell.
a_P_ = .355.
b_P_ = .092.
c_P_ < .00001.
Table 1.
Characteristics of Subjects
| Characteristic | Aseptic Failure (n = 195) | PJI (n = 213) |
|---|---|---|
| Agea, y, mean (range) | 64.8 (18–89) | 65.8 (30–93) |
| Sexb, female, No. (%) | 106 (54) | 98 (46) |
| Site of arthroplastyc, No. (%) | ||
| Knee | 155 (79) | 126 (59) |
| Hip | 40 (21) | 87 (41) |
| IDSA PJI criteria, No. | ||
| Purulence visible intraoperatively | 0 | 130 |
| Presence of sinus tract | 0 | 52 |
| Identical organism identified with 2 separate cultures | 0 | 111 |
| Acute inflammation on histopathology | 1 of 170 | 113 of 144 |
| Antibiotics within 4 wk prior to surgery | 10 | 131 |
| Laboratory parameters, median (range) | ||
| Hemoglobin, mg/dL | 13.6 (7.2–17.7) | 11.7 (5–15.7) |
| WBC count, 103 cells/µL | 6.8 (3.0–48.6) | 7.8 (3.1–40.6) |
| ESR, mm/h (reference range, 0–22) | 9 (0–109) | 40 (1–130) |
| CRP, mg/L (reference range, 0–8.0) | 3.8 (1–245) | 31.8 (3–400) |
| Characteristic | Aseptic Failure (n = 195) | PJI (n = 213) |
|---|---|---|
| Agea, y, mean (range) | 64.8 (18–89) | 65.8 (30–93) |
| Sexb, female, No. (%) | 106 (54) | 98 (46) |
| Site of arthroplastyc, No. (%) | ||
| Knee | 155 (79) | 126 (59) |
| Hip | 40 (21) | 87 (41) |
| IDSA PJI criteria, No. | ||
| Purulence visible intraoperatively | 0 | 130 |
| Presence of sinus tract | 0 | 52 |
| Identical organism identified with 2 separate cultures | 0 | 111 |
| Acute inflammation on histopathology | 1 of 170 | 113 of 144 |
| Antibiotics within 4 wk prior to surgery | 10 | 131 |
| Laboratory parameters, median (range) | ||
| Hemoglobin, mg/dL | 13.6 (7.2–17.7) | 11.7 (5–15.7) |
| WBC count, 103 cells/µL | 6.8 (3.0–48.6) | 7.8 (3.1–40.6) |
| ESR, mm/h (reference range, 0–22) | 9 (0–109) | 40 (1–130) |
| CRP, mg/L (reference range, 0–8.0) | 3.8 (1–245) | 31.8 (3–400) |
Abbreviations: CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IDSA, Infectious Diseases Society of America; PJI, prosthetic joint infection; WBC, white blood cell.
a_P_ = .355.
b_P_ = .092.
c_P_ < .00001.
Analysis of Aseptic Failure
To test whether microorganisms were present in prosthetic joints that failed for reasons other than infection (aseptic loosening, adverse local tissue response, instability, periprosthetic fracture, etc), 195 sonicate fluids generated from uninfected prostheses were analyzed by shotgun metagenomics. Of these, 7 (3.6%) contained sufficient sequences and reference genome coverage to indicate the possible presence of bacteria (Tables 2 and 3). The detected species are all known to cause PJI (Table 4). In 6 of 7 cases, the organism was detected with both analytic tools, with 1 case identified with Livermore Metagenomics Analysis Toolkit (LMAT) alone (Supplementary Table 1). Large numbers of microbial reads were present in many of the uninfected samples, reflecting contaminant DNA sequences common to metagenomics, particularly in samples with low-input DNA after removal of human DNA (Supplementary Table 1). Alignment of these reads to reference genomes invariably resulted in high coverage depth of short genome fragments rather than being distributed across a genome, a pattern often present in negative controls with reagents only and no input sample.
Table 2.
Performance of Metagenomic Shotgun Sequencing Versus Sonicate Fluid Culture
| Case Classification | Samples, No. | Identical Findings | Organisms Not Identified by Metagenomics | New Organisms Detected by Metagenomics |
|---|---|---|---|---|
| Aseptic failure | 195 | 188 (96.4) | NA | 7 (3.6) |
| Culture-positive PJI | 115 | 99 (86.1) | 6 (5.2) | 11 (9.6) |
| Culture-negative PJI | 98 | 55 (56.1) | NA | 43 (43.9) |
| Case Classification | Samples, No. | Identical Findings | Organisms Not Identified by Metagenomics | New Organisms Detected by Metagenomics |
|---|---|---|---|---|
| Aseptic failure | 195 | 188 (96.4) | NA | 7 (3.6) |
| Culture-positive PJI | 115 | 99 (86.1) | 6 (5.2) | 11 (9.6) |
| Culture-negative PJI | 98 | 55 (56.1) | NA | 43 (43.9) |
Abbreviations: NA, not applicable; PJI, prosthetic joint infection.
Data are the No. (%) of samples in which identical findings or discrepant findings between sonicate fluid culture and metagenomic sequencing were observed.
Table 2.
Performance of Metagenomic Shotgun Sequencing Versus Sonicate Fluid Culture
| Case Classification | Samples, No. | Identical Findings | Organisms Not Identified by Metagenomics | New Organisms Detected by Metagenomics |
|---|---|---|---|---|
| Aseptic failure | 195 | 188 (96.4) | NA | 7 (3.6) |
| Culture-positive PJI | 115 | 99 (86.1) | 6 (5.2) | 11 (9.6) |
| Culture-negative PJI | 98 | 55 (56.1) | NA | 43 (43.9) |
| Case Classification | Samples, No. | Identical Findings | Organisms Not Identified by Metagenomics | New Organisms Detected by Metagenomics |
|---|---|---|---|---|
| Aseptic failure | 195 | 188 (96.4) | NA | 7 (3.6) |
| Culture-positive PJI | 115 | 99 (86.1) | 6 (5.2) | 11 (9.6) |
| Culture-negative PJI | 98 | 55 (56.1) | NA | 43 (43.9) |
Abbreviations: NA, not applicable; PJI, prosthetic joint infection.
Data are the No. (%) of samples in which identical findings or discrepant findings between sonicate fluid culture and metagenomic sequencing were observed.
Table 3.
Metagenomic Sequencing Versus All Cultures From All Sources (Intraoperative Tissue, Preoperative Synovial Fluid, and Sonicate Fluid)
| Case Classification | Samples, No. | Identical Findings | Organisms Not Identified by Metagenomics | New Organisms Detected by Metagenomics |
|---|---|---|---|---|
| Aseptic failure | 195 | 188 (96.4) | NA | 7 (3.6) |
| Culture-positive PJI | 146 | 121 (82.9) | 16 (11.0) | 12 (8.2) |
| Culture-negative PJI | 67 | 46 (68.7) | NA | 21 (31.3) |
| Case Classification | Samples, No. | Identical Findings | Organisms Not Identified by Metagenomics | New Organisms Detected by Metagenomics |
|---|---|---|---|---|
| Aseptic failure | 195 | 188 (96.4) | NA | 7 (3.6) |
| Culture-positive PJI | 146 | 121 (82.9) | 16 (11.0) | 12 (8.2) |
| Culture-negative PJI | 67 | 46 (68.7) | NA | 21 (31.3) |
Abbreviations: NA, not applicable; PJI, prosthetic joint infection.
Data are the No. (%) of samples in which identical findings or discrepant findings between sonicate fluid culture and metagenomic sequencing were observed.
Table 3.
Metagenomic Sequencing Versus All Cultures From All Sources (Intraoperative Tissue, Preoperative Synovial Fluid, and Sonicate Fluid)
| Case Classification | Samples, No. | Identical Findings | Organisms Not Identified by Metagenomics | New Organisms Detected by Metagenomics |
|---|---|---|---|---|
| Aseptic failure | 195 | 188 (96.4) | NA | 7 (3.6) |
| Culture-positive PJI | 146 | 121 (82.9) | 16 (11.0) | 12 (8.2) |
| Culture-negative PJI | 67 | 46 (68.7) | NA | 21 (31.3) |
| Case Classification | Samples, No. | Identical Findings | Organisms Not Identified by Metagenomics | New Organisms Detected by Metagenomics |
|---|---|---|---|---|
| Aseptic failure | 195 | 188 (96.4) | NA | 7 (3.6) |
| Culture-positive PJI | 146 | 121 (82.9) | 16 (11.0) | 12 (8.2) |
| Culture-negative PJI | 67 | 46 (68.7) | NA | 21 (31.3) |
Abbreviations: NA, not applicable; PJI, prosthetic joint infection.
Data are the No. (%) of samples in which identical findings or discrepant findings between sonicate fluid culture and metagenomic sequencing were observed.
Table 4.
Species From Discordant Samples
| Discrepancy Between Methods | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture |
|---|---|---|---|
| PJI organisms not detected by metagenomics | Bacillus spp_Candida albicans_ | Mycobacterium abscessus Porphyromonas species | Pseudomonas aeruginosa (2) |
| New organisms detected in aseptic failure | Cutibacterium acnes (2) | Staphylococcus aureus (3) | Streptococcus sanguinis (2) |
| New organisms detected in culture-positive PJI | Anaerococcus obesiensis Clostridium species_C. acnes_ _Enterobacter cloacae_a | Finegoldia magna (3)a_Peptoniphilus harei_ Prevotella nanciensis S. aureus | Staphylococcus epidermidis (5)Staphylococcus lugdunensis (3)Varibaculum cambriense |
| New organisms detected in culture-negative PJI | Anaerococcus urinae C. albicans (2)a_Candida parapsilosis_a_Clostridium perfringens_ Corynebacterium pseudogenitalium C. acnes Enterococcus faecalis (3)a | E. cloacae (2)a_Facklamia languida_ Granulicatella adiacens (2)a_Mycobacterium bovis_ BCGa_Mycoplasma salivarium_ Peptoniphilus species_Pasteurella multocida_a | S. aureus (10)a_S. epidermidis_ (5)a_Staphylococcus haemolyticus_ (2)a_S. lugdunensis_ Streptococcus agalactiae (4)Streptococcus dysgalactiae (4)a_Streptococcus oralis_a |
| Discrepancy Between Methods | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture |
|---|---|---|---|
| PJI organisms not detected by metagenomics | Bacillus spp_Candida albicans_ | Mycobacterium abscessus Porphyromonas species | Pseudomonas aeruginosa (2) |
| New organisms detected in aseptic failure | Cutibacterium acnes (2) | Staphylococcus aureus (3) | Streptococcus sanguinis (2) |
| New organisms detected in culture-positive PJI | Anaerococcus obesiensis Clostridium species_C. acnes_ _Enterobacter cloacae_a | Finegoldia magna (3)a_Peptoniphilus harei_ Prevotella nanciensis S. aureus | Staphylococcus epidermidis (5)Staphylococcus lugdunensis (3)Varibaculum cambriense |
| New organisms detected in culture-negative PJI | Anaerococcus urinae C. albicans (2)a_Candida parapsilosis_a_Clostridium perfringens_ Corynebacterium pseudogenitalium C. acnes Enterococcus faecalis (3)a | E. cloacae (2)a_Facklamia languida_ Granulicatella adiacens (2)a_Mycobacterium bovis_ BCGa_Mycoplasma salivarium_ Peptoniphilus species_Pasteurella multocida_a | S. aureus (10)a_S. epidermidis_ (5)a_Staphylococcus haemolyticus_ (2)a_S. lugdunensis_ Streptococcus agalactiae (4)Streptococcus dysgalactiae (4)a_Streptococcus oralis_a |
Abbreviation: PJI, prosthetic joint infection.
Listed are species identified or missed by shotgun metagenomics compared to sonicate fluid culture alone. Values in parentheses indicate detection in >1 subject; the number given is the number of subjects.
aIndicates organism identified in cultures other than sonicate fluid.
Table 4.
Species From Discordant Samples
| Discrepancy Between Methods | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture |
|---|---|---|---|
| PJI organisms not detected by metagenomics | Bacillus spp_Candida albicans_ | Mycobacterium abscessus Porphyromonas species | Pseudomonas aeruginosa (2) |
| New organisms detected in aseptic failure | Cutibacterium acnes (2) | Staphylococcus aureus (3) | Streptococcus sanguinis (2) |
| New organisms detected in culture-positive PJI | Anaerococcus obesiensis Clostridium species_C. acnes_ _Enterobacter cloacae_a | Finegoldia magna (3)a_Peptoniphilus harei_ Prevotella nanciensis S. aureus | Staphylococcus epidermidis (5)Staphylococcus lugdunensis (3)Varibaculum cambriense |
| New organisms detected in culture-negative PJI | Anaerococcus urinae C. albicans (2)a_Candida parapsilosis_a_Clostridium perfringens_ Corynebacterium pseudogenitalium C. acnes Enterococcus faecalis (3)a | E. cloacae (2)a_Facklamia languida_ Granulicatella adiacens (2)a_Mycobacterium bovis_ BCGa_Mycoplasma salivarium_ Peptoniphilus species_Pasteurella multocida_a | S. aureus (10)a_S. epidermidis_ (5)a_Staphylococcus haemolyticus_ (2)a_S. lugdunensis_ Streptococcus agalactiae (4)Streptococcus dysgalactiae (4)a_Streptococcus oralis_a |
| Discrepancy Between Methods | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture | New or Missed Identifications by Metagenomics vs Sonicate Fluid Culture |
|---|---|---|---|
| PJI organisms not detected by metagenomics | Bacillus spp_Candida albicans_ | Mycobacterium abscessus Porphyromonas species | Pseudomonas aeruginosa (2) |
| New organisms detected in aseptic failure | Cutibacterium acnes (2) | Staphylococcus aureus (3) | Streptococcus sanguinis (2) |
| New organisms detected in culture-positive PJI | Anaerococcus obesiensis Clostridium species_C. acnes_ _Enterobacter cloacae_a | Finegoldia magna (3)a_Peptoniphilus harei_ Prevotella nanciensis S. aureus | Staphylococcus epidermidis (5)Staphylococcus lugdunensis (3)Varibaculum cambriense |
| New organisms detected in culture-negative PJI | Anaerococcus urinae C. albicans (2)a_Candida parapsilosis_a_Clostridium perfringens_ Corynebacterium pseudogenitalium C. acnes Enterococcus faecalis (3)a | E. cloacae (2)a_Facklamia languida_ Granulicatella adiacens (2)a_Mycobacterium bovis_ BCGa_Mycoplasma salivarium_ Peptoniphilus species_Pasteurella multocida_a | S. aureus (10)a_S. epidermidis_ (5)a_Staphylococcus haemolyticus_ (2)a_S. lugdunensis_ Streptococcus agalactiae (4)Streptococcus dysgalactiae (4)a_Streptococcus oralis_a |
Abbreviation: PJI, prosthetic joint infection.
Listed are species identified or missed by shotgun metagenomics compared to sonicate fluid culture alone. Values in parentheses indicate detection in >1 subject; the number given is the number of subjects.
aIndicates organism identified in cultures other than sonicate fluid.
Shotgun Metagenomics Compared to Sonicate Fluid Culture
During clinical evaluation of a potentially infected arthroplasty, there are typically multiple cultures from various sources including synovial fluid, intraoperative tissue specimens, and sonicate fluid, the last generated in an attempt to dislodge bacteria adherent to the prostheses after removal. Sonicate fluid was the only sample tested by metagenomics herein; therefore, metagenomic results were initially compared directly to culture results from sonicate fluid. In these analyses, cases where <20 CFU/10 mL of bacteria were detected were considered negative as is the case in our routine clinical practice.
Of the 213 sonicate fluid specimens from subjects with PJI, 115 (54%) were culture positive and 98 (46%) were culture negative (Table 2). Of the 115 culture-positive cases, the pathogens identified by culture were also detected by metagenomics in 109 (94.8%) cases. Metagenomics provided identical findings to those of culture in 99 (86.1%) cases, with additional potential pathogens detected in 11 (9.6%) cases. Four of these 11 were known polymicrobial infections in which additional potential pathogens were detected. The other 7 cases appeared to be monomicrobial by culture but were found to have at least 1 new potential pathogen. In 1 case (sample 588), the species identified by both metagenomic analytic tools (Peptoniphilus harei) was different from that determined by conventional techniques, including 16S rRNA gene sequencing and quick indole testing (Peptoniphilus indolicus).
In 6 cases, a pathogen detected by culture was not detected using metagenomics. Two of these (samples 838 and 1031) were polymicrobial infections and only 1 pathogen was detected by metagenomics. In 2 cases (sample 793, a Candida albicans PJI, and sample 1041, a Mycobacterium abscessus PJI), sonicate fluid cultures were not quantified, so it is unknown if these would have met the ≥20 CFU/10 mL threshold for being considered culture-positive by sonicate fluid culture. In 2 other samples (samples 559 and 813), the undetected pathogen was Pseudomonas aeruginosa. Subsequent testing revealed that certain P. aeruginosa strains may be more susceptible to DNA degradation during the MolYsis microbial enrichment steps, whereas other tested species including M. abscessus, Escherichia coli, and Enterobacter cloacae isolates were not lysed during MolYsis treatment (data not shown).
Of the 98 cases considered to be culture negative by sonicate fluid culture, potential pathogens were detected in 43 (43.9%) using metagenomics. The microorganisms identified largely consisted of those previously reported as PJI pathogens (Table 4). One novel PJI pathogen, Mycoplasma salivarium, was identified, as previously reported [14]. Of these new identifications, 19 had been found by culture in specimen types other than sonicate fluid, whereas 24 cases reflected novel detections (ie, not otherwise found) through metagenomics.
Shotgun Metagenomics Compared to All Culture Sources
To better reflect all data available in a clinical scenario, metagenomic results were compared to all available culture results, including intraoperative tissue and synovial fluid cultured any time prior to surgery. With these, an additional 31 PJI cases were classified as culture positive (Table 3). Metagenomics resulted in identical identifications in 121 of 146 (82.9%) culture-positive cases, with additional potential pathogens detected in 12 cases. However, 16 (11.0%) cases had at least 1 known pathogen not detected by metagenomics. In 14 of these cases, antibiotics had been administered prior to prosthesis removal. In 7 cases, there was no growth from the sonicate fluid that was being used for metagenomic analysis. Metagenomics was still able to identify new potential pathogens in 21 of 67 (31.3%) culture-negative cases.
Read Counts of Detected Microorganisms
Read counts identified as the primary pathogen or potential pathogen were calculated to estimate the depth of genome coverage, which is important for gene content interpretative analyses, such as antibiotic resistance prediction. Of the 110 pathogens detected by culture, the average number of paired-end reads attributable to the known pathogen was 4989251, with a median of 1978090 reads per pathogen, and up to 32892968 reads (out of 37499849 total) in 1 sample (Table 5). Reads counts for noncultured potential pathogens were fewer, with the average number of reads from the 3 other categories ranging from 113969 reads in the aseptic failure cases, up to 1948403 reads from new potential pathogens not previously identified in culture-positive PJI cases.
Table 5.
Read Counts for the Top Known or Potential Pathogen Identified in Samples as Identified by Livermore Metagenomics Analysis Toolkit at the Genus Level
| Statistics | Organisms Also Detected by Sonicate Fluid Culture, No. | New Potential Pathogens Identified, No. | ||
|---|---|---|---|---|
| Culture-Positive PJI | Culture-Negative PJI | Aseptic Failure | ||
| No. of samples | 110 | 10 | 43 | 7 |
| Median | 1978090 | 11786 | 21762 | 24059 |
| Mean | 4989251 | 1948403 | 384630 | 113969 |
| Minimum | 117 | 595 | 100 | 5392 |
| Maximum | 32892968 | 10196578 | 3976409 | 433462 |
| Statistics | Organisms Also Detected by Sonicate Fluid Culture, No. | New Potential Pathogens Identified, No. | ||
|---|---|---|---|---|
| Culture-Positive PJI | Culture-Negative PJI | Aseptic Failure | ||
| No. of samples | 110 | 10 | 43 | 7 |
| Median | 1978090 | 11786 | 21762 | 24059 |
| Mean | 4989251 | 1948403 | 384630 | 113969 |
| Minimum | 117 | 595 | 100 | 5392 |
| Maximum | 32892968 | 10196578 | 3976409 | 433462 |
Abbreviation: PJI, prosthetic joint infection.
Table 5.
Read Counts for the Top Known or Potential Pathogen Identified in Samples as Identified by Livermore Metagenomics Analysis Toolkit at the Genus Level
| Statistics | Organisms Also Detected by Sonicate Fluid Culture, No. | New Potential Pathogens Identified, No. | ||
|---|---|---|---|---|
| Culture-Positive PJI | Culture-Negative PJI | Aseptic Failure | ||
| No. of samples | 110 | 10 | 43 | 7 |
| Median | 1978090 | 11786 | 21762 | 24059 |
| Mean | 4989251 | 1948403 | 384630 | 113969 |
| Minimum | 117 | 595 | 100 | 5392 |
| Maximum | 32892968 | 10196578 | 3976409 | 433462 |
| Statistics | Organisms Also Detected by Sonicate Fluid Culture, No. | New Potential Pathogens Identified, No. | ||
|---|---|---|---|---|
| Culture-Positive PJI | Culture-Negative PJI | Aseptic Failure | ||
| No. of samples | 110 | 10 | 43 | 7 |
| Median | 1978090 | 11786 | 21762 | 24059 |
| Mean | 4989251 | 1948403 | 384630 | 113969 |
| Minimum | 117 | 595 | 100 | 5392 |
| Maximum | 32892968 | 10196578 | 3976409 | 433462 |
Abbreviation: PJI, prosthetic joint infection.
DISCUSSION
Metagenomic shotgun sequencing has the potential to enhance or change how many difficult-to-detect pathogens are identified. Using this approach to evaluate sonicate fluids generated from 408 resected arthroplasties, we observed that metagenomics was able to detect most pathogens identified by culture (89.0%–94.8% depending on culture positivity definition), as well as many that were not detected by culture. This was particularly true in the culture-negative PJI group in which potential pathogens were detected in 43.9% of cases with no sonicate fluid growth. Of these, 48.8% (21 of 43) were not found in cultures of other sources, that is, intraoperative tissue specimens or synovial fluid.
The species newly detected by metagenomics as potential pathogens consisted largely of common PJI pathogens (Table 4). Some notable exceptions included M. salivarium and Mycobacterium bovis bacillus Calmette-Guérin, bacteria that can go undetected with routine bacterial culture techniques. Interestingly, the individual with M. salivarium detected by metagenomics (sample 1116) later developed recurrent PJI and M. salivarium was detected using molecular techniques, as previously reported [14], as well as by specialized culture.
Street et al recently published similar findings using a metagenomic sequencing approach to PJI pathogen identification with a genus-level sensitivity of 93% (64/69 samples) despite differences in techniques, including microbial DNA enrichment methods (NebNext microbiome enrichment kit vs MolYsis kit), sequencing methods (MiSeq vs HiSeq 2500), and analytic tools (Kraken vs LMAT and MetaPlan2) [15]. The use of MolYsis reagents and sequencing at higher depths reported here allowed a larger proportion and number of reads from organisms detected. More complete coverage is important when performing additional analyses such as gene content, including antibiotic resistance prediction, which requires complete coverage of genomes at sufficient depth to provide confidence in predicting that a resistance-conferring gene or mutation is not present [9]. Ruppé et al also recently published a study using metagenomics to examine a variety of orthopedic infections [20]. Of the 104 samples tested, 24 specimens from 14 individuals contained sufficient DNA to perform metagenomic sequencing. Known pathogens were detected in all (8) monomicrobial specimens, while 74.5% of isolates from polymicrobial samples were detected at the genus level. They too observed large numbers of additional species. While some of them were plausible given the source (eg, mandibular or sacral infections), the overall pattern and presence of species in negative controls suggests contaminant reagent DNA to be problematic.
In every sample tested, there were reads assigned to microorganisms other than known or suspected pathogens, including in uninfected cases and negative controls. This is a major challenge in the field of metagenomics as it is a common problem and can interfere with reliable identification of pathogens [10–12]. This is further complicated by the common contaminants (eg, Acinetobacter, Streptococcus, Cutibacterium, and Staphylococcus species) also being among common causes of PJI [11, 13]. We and others have observed that these background reads are largely attributable to the reagents used, as the composition can change when different brands of kits are used during DNA preparation. When analyzing negative controls or uninfected samples, we have observed that when large numbers of background reads are observed, this is due to high coverage of a few small fragments (typically <1 kb). This observation was useful to help determine “real” vs background reads by aligning reads from a sample to reference genomes; if the standard deviation was 10-fold greater than the average depth of coverage, the organism was determined to be a likely contaminant.
It is interesting that with the various sources tested by culture and metagenomic analysis of sonicate fluid, 46 cases that appeared to be infected by clinical criteria remained without a potential pathogen identified. Of these, 27 had received 1 or more antibiotics within 4 weeks prior to surgery, which is known to increase the risk of culture-negative PJI [21]. Another likely contributor is the lack of a gold standard for PJI vs aseptic failure diagnosis. PJI classification is based on a combination of clinical, microbiological, and histological findings; although some subjects may fit 1 or more criteria for PJI classification, the joint may not have actually been infected. Limitations of reference databases can also lead to microorganisms not being detected using a metagenomics approach [22]. We observed examples of this while using 2 separate analysis tools, LMAT and MetaPhlAn2. For example, samples 637, 765, and 930 each contained >1 million reads from known pathogens, yet were not detected using MetaPhlAn2 (Supplementary Table 1). These discrepancies highlight the utility of using multiple analytic tools to help overcome deficiencies of individual methods or databases.
The role of bacteria or other microorganisms as contributors to aseptic loosening or other causes of aseptic failure continues to be an active area of research. We analyzed a large set of arthroplasties removed for reasons other than infection and, of the 195 samples tested, only 7 had sufficient microbial reads beyond that of negative controls to be considered potentially positive. While these results do not rule out a potential role of microorganisms in the other 188 cases, we were unable to find evidence of the presence of bacteria in higher proportions of samples as has been reported previously using other methods [4, 5].
There are limitations to this study and the methods used. Accurate case definition and limitations of sequence databases are mentioned above. MolYsis was used for microbial DNA enrichment, and whereas multiple studies have published the wide range of bacteria detectable by PCR after MolYsis treatment, we observed that some P. aeruginosa strains were susceptible to DNA degradation by MolYsis pretreatment, raising the question as to whether other pathogens may have been selected against using this method [23]. Alternative microbial DNA enrichment techniques are available but have the potential to introduce other biases [24]. Skipping microbial enrichment and sequencing at much higher depths is another possibility but greatly increases the cost per sample and would still result in too few reads to reliably obtain useful information regarding gene content in many cases [9].
The role of metagenomics in infectious disease diagnostics continues to evolve. Case reports have highlighted its value in select situations where no pathogen is identified by conventional testing methods [14, 22]. Small series of samples have also addressed the utility in specific specimen types, such as urine and feces [16, 17, 25]. High costs and slow turnaround times are barriers to routine use; however, improving technology continues to make sequencing and subsequent analysis faster and less expensive. For these studies, the sequencing method (HiSeq 2500 rapid run mode, 2 × 250 cycles) alone takes approximately 60 hours to run, putting total process time with sample preparation and analysis at approximately 6 days. Given that metagenomics found identical results to those of culture in the large majority of aseptic failures and culture-positive PJIs, the highest-yield use of metagenomics would likely come from using it in PJI cases where no pathogen is identified with initial culture. Subsequent studies are needed to determine the utility of metagenomics vs other methods, such as 16S and 18S rRNA gene PCR/sequencing, which is becoming increasingly available; the role for metagenomics may also be after these molecular methods fail to identify a potential pathogen or if additional gene content information is needed for treatment decisions.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.
Notes
Disclaimer. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH).
Financial support. This work was supported by the NIH (award number R01 AR056647). N. C. is supported by the NIH (award number R01 CA179243).
Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
Kurtz
SM
,
Lau
E
,
Watson
H
,
Schmier
JK
,
Parvizi
J
.
Economic burden of periprosthetic joint infection in the United States
.
J Arthroplasty
2012
;
27
:
61
–
5.e1
.
Tande
AJ
,
Patel
R
.
Prosthetic joint infection
.
Clin Microbiol Rev
2014
;
27
:
302
–
45
.
Peel
TN
,
Cheng
AC
,
Buising
KL
,
Choong
PF
.
Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective
?
Antimicrob Agents Chemother
2012
;
56
:
2386
–
91
.
Moojen
DJ
,
van Hellemondt
G
,
Vogely
HC
, et al.
Incidence of low-grade infection in aseptic loosening of total hip arthroplasty
.
Acta Orthop
2010
;
81
:
667
–
73
.
Kobayashi
N
,
Procop
GW
,
Krebs
V
,
Kobayashi
H
,
Bauer
TW
.
Molecular identification of bacteria from aseptically loose implants
.
Clin Orthop Relat Res
2008
;
466
:
1716
–
25
.
Qin
N
,
Yang
F
,
Li
A
, et al.
Alterations of the human gut microbiome in liver cirrhosis
.
Nature
2014
;
513
:
59
–
64
.
Be
NA
,
Thissen
JB
,
Fofanov
VY
, et al.
Metagenomic analysis of the airborne environment in urban spaces
.
Microb Ecol
2015
;
69
:
346
–
55
.
Gibson
MK
,
Forsberg
KJ
,
Dantas
G
.
Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology
.
ISME J
2015
;
9
:
207
–
16
.
Thoendel
M
,
Jeraldo
PR
,
Greenwood-Quaintance
KE
, et al.
Comparison of microbial DNA enrichment tools for metagenomic whole genome sequencing
.
J Microbiol Methods
2016
;
127
:
141
–
5
.
Laurence
M
,
Hatzis
C
,
Brash
DE
.
Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes
.
PLoS One
2014
;
9
:
e97876
.
Salter
SJ
,
Cox
MJ
,
Turek
EM
, et al.
Reagent and laboratory contamination can critically impact sequence-based microbiome analyses
.
BMC Biol
2014
;
12
:
87
.
Perlejewski
K
,
Bukowska-Ośko
I
,
Nakamura
S
, et al.
Metagenomic analysis of cerebrospinal fluid from patients with multiple sclerosis
.
Adv Exp Med Biol
2016
;
935
:
89
–
98
.
Thoendel
M
,
Jeraldo
P
,
Greenwood-Quaintance
KE
, et al.
Impact of contaminating DNA in whole-genome amplification kits used for metagenomic shotgun sequencing for infection diagnosis
.
J Clin Microbiol
2017
;
55
:
1789
–
801
.
Thoendel
M
,
Jeraldo
P
,
Greenwood-Quaintance
KE
, et al.
A novel prosthetic joint infection pathogen, Mycoplasma salivarium, identified by metagenomic shotgun sequencing
.
Clin Infect Dis
2017
;
65
:
332
–
5
.
Street
TL
,
Sanderson
ND
,
Atkins
BL
, et al.
Molecular diagnosis of orthopedic-device-related infection directly from sonication fluid by metagenomic sequencing
.
J Clin Microbiol
2017
;
55
:
2334
–
47
.
Hasman
H
,
Saputra
D
,
Sicheritz-Ponten
T
, et al.
Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples
.
J Clin Microbiol
2014
;
52
:
139
–
46
.
Joensen
KG
,
Engsbro
ALØ
,
Lukjancenko
O
, et al.
Evaluating next-generation sequencing for direct clinical diagnostics in diarrhoeal disease
.
Eur J Clin Microbiol Infect Dis
2017
;
36
:
1325
–
38
.
Trampuz
A
,
Piper
KE
,
Jacobson
MJ
, et al.
Sonication of removed hip and knee prostheses for diagnosis of infection
.
N Engl J Med
2007
;
357
:
654
–
63
.
Osmon
DR
,
Berbari
EF
,
Berendt
AR
, et al. ;
Infectious Diseases Society of America
.
Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America
.
Clin Infect Dis
2013
;
56
:
e1
–
e25
.
Ruppé
E
,
Lazarevic
V
,
Girard
M
, et al.
Clinical metagenomics of bone and joint infections: a proof of concept study
.
Sci Rep
2017
;
7
:
7718
.
Malekzadeh
D
,
Osmon
DR
,
Lahr
BD
,
Hanssen
AD
,
Berbari
EF
.
Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection
.
Clin Orthop Relat Res
2010
;
468
:
2039
–
45
.
Greninger
AL
,
Messacar
K
,
Dunnebacke
T
, et al.
Clinical metagenomic identification of Balamuthia mandrillaris encephalitis and assembly of the draft genome: the continuing case for reference genome sequencing
.
Genome Med
2015
;
7
:
113
.
Gebert
S
,
Siegel
D
,
Wellinghausen
N
.
Rapid detection of pathogens in blood culture bottles by real-time PCR in conjunction with the pre-analytic tool MolYsis
.
J Infect
2008
;
57
:
307
–
16
.
Feehery
GR
,
Yigit
E
,
Oyola
SO
, et al.
A method for selectively enriching microbial DNA from contaminating vertebrate host DNA
.
PLoS One
2013
;
8
:
e76096
.
Schmidt
K
,
Mwaigwisya
S
,
Crossman
LC
, et al.
Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by Nanopore-based metagenomic sequencing
.
J Antimicrob Chemother
2017
;
72
:
104
–
14
.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
Topic:
- dna
- infections
- pathogenic organism
- prosthetic joint infections
- microorganisms
- metagenomics
- shotgun sequencing